全文获取类型
收费全文 | 1558篇 |
免费 | 188篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 143篇 |
妇产科学 | 24篇 |
基础医学 | 206篇 |
口腔科学 | 90篇 |
临床医学 | 162篇 |
内科学 | 310篇 |
皮肤病学 | 49篇 |
神经病学 | 31篇 |
特种医学 | 173篇 |
外科学 | 224篇 |
综合类 | 38篇 |
预防医学 | 94篇 |
眼科学 | 40篇 |
药学 | 65篇 |
中国医学 | 2篇 |
肿瘤学 | 117篇 |
出版年
2023年 | 15篇 |
2022年 | 10篇 |
2021年 | 13篇 |
2020年 | 15篇 |
2019年 | 8篇 |
2018年 | 45篇 |
2017年 | 47篇 |
2016年 | 41篇 |
2015年 | 64篇 |
2014年 | 79篇 |
2013年 | 109篇 |
2012年 | 51篇 |
2011年 | 38篇 |
2010年 | 79篇 |
2009年 | 98篇 |
2008年 | 38篇 |
2007年 | 52篇 |
2006年 | 52篇 |
2005年 | 33篇 |
2004年 | 30篇 |
2003年 | 17篇 |
2002年 | 21篇 |
2001年 | 18篇 |
2000年 | 9篇 |
1999年 | 24篇 |
1998年 | 101篇 |
1997年 | 86篇 |
1996年 | 98篇 |
1995年 | 63篇 |
1994年 | 74篇 |
1993年 | 39篇 |
1992年 | 14篇 |
1991年 | 23篇 |
1990年 | 13篇 |
1989年 | 31篇 |
1988年 | 29篇 |
1987年 | 28篇 |
1986年 | 26篇 |
1985年 | 24篇 |
1984年 | 12篇 |
1983年 | 9篇 |
1982年 | 20篇 |
1981年 | 15篇 |
1980年 | 16篇 |
1979年 | 5篇 |
1978年 | 6篇 |
1977年 | 9篇 |
1976年 | 13篇 |
1975年 | 9篇 |
1966年 | 1篇 |
排序方式: 共有1774条查询结果,搜索用时 328 毫秒
91.
92.
93.
94.
G Lavie ; Y Mazur ; D Lavie ; AM Prince ; D Pascual ; L Liebes ; B Levin ; D Meruelo 《Transfusion》1995,35(5):392-400
95.
96.
97.
98.
Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies 总被引:6,自引:7,他引:6
Bi L; Sarkar R; Naas T; Lawler AM; Pain J; Shumaker SL; Bedian V; Kazazian HH Jr 《Blood》1996,88(9):3446-3450
99.
Roccaro AM Leleu X Sacco A Jia X Melhem M Moreau AS Ngo HT Runnels J Azab A Azab F Burwick N Farag M Treon SP Palladino MA Hideshima T Chauhan D Anderson KC Ghobrial IM 《Blood》2008,111(9):4752-4763
Waldenström macroglobulinemia (WM) is an incurable low-grade B-cell lymphoma characterized by high protein turnover. We dissected the biologic role of the proteasome in WM using 2 proteasome inhibitors, NPI-0052 and bortezomib. We found that NPI-0052 inhibited proliferation and induced apoptosis in WM cells, and that the combination of NPI-0052 and bortezomib induced synergistic cytotoxicity in WM cells, leading to inhibition of nuclear translocation of p65NF-B and synergistic induction of caspases-3, -8, and -9 and PARP cleavage. These 2 agents inhibited the canonical and noncanonical NF-B pathways and acted synergistically through their differential effect on Akt activity and on chymotrypsin-like, caspaselike, and trypsinlike activities of the proteasome. We demonstrated that NPI-0052–induced cytotoxicity was completely abrogated in an Akt knockdown cell line, indicating that its major activity is mediated through the Akt pathway. Moreover, we demonstrated that NPI-0052 and bortezomib inhibited migration and adhesion in vitro and homing of WM cells in vivo, and overcame resistance induced by mesenchymal cells or by the addition of interleukin-6 in a coculture in vitro system. Theses studies enhance our understanding of the biologic role of the proteasome pathway in WM, and provide the preclinical basis for clinical trials of combinations of proteasome inhibitors in WM. 相似文献
100.
Maternal administration of granulocyte colony-stimulating factor improves neonatal rat survival after a lethal group B streptococcal infection 总被引:2,自引:0,他引:2
Novales JS; Salva AM; Modanlou HD; Kaplan DL; del Castillo J; Andersen J; Medlock ES 《Blood》1993,81(4):923-927
Maternally administered recombinant human granulocyte colony- stimulating factor (rhG-CSF) has been shown to cross the placenta and induce a peripheral neutrophilia and increases in the marrow and spleen neutrophil storage pools in fetal and newborn rats. In the present study, we have used this model system to investigate the efficacy of prenatally administered rhG-CSF on neonatal defense to a lethal challenge with Group B-beta hemolytic Streptococcus (GBS). Pregnant rats were injected with rhG-CSF twice daily beginning 6 days before parturition. At birth, all pups were infected with a dose of GBS that is lethal for 90% of infected pups (LD90). Survival was monitored daily for 5 days. Survival of infected pups from saline-treated mothers beyond 60 hours after infection was 10%. No difference in survival was observed among pups from mothers treated 2 and 4 days before parturition. In contrast, we determined that survival was 82.5% among infected pups from mothers treated for 6 days before parturition with rhG-CSF. Our results demonstrate that maternal administration of rhG- CSF augments neonatal defenses against a lethal bacterial challenge. 相似文献